Clinical Trials Sponsored by Alucent Biomedical

Total 2287 results

Alucent Biomedical

Completed

Natural Vascular Scaffold (NVS) Therapy for Treatment of Atherosclerotic Lesions (Activate I)

Peripheral Arterial Disease | Peripheral Vascular Diseases | Catheterization, Peripheral

United States
Alucent Biomedical

Recruiting

Alucent Vessel Restoration System for AVF (Activate AVF)

AV Fistula

Australia, Poland
Alucent Biomedical

Active, not recruiting

Feasibility Study of the Vessel Restoration System (VRS) for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Popliteal Artery (PA) After Sub-optimal Percutaneous Transluminal Angioplasty (PTA) or Atherectomy: REACTIVATE I (REACTIVATE I)

PAD - Peripheral Arterial Disease

Australia
Alucent Biomedical

Active, not recruiting

Feasibility Study of the Vessel Restoration System (VRS): ACTIVATE II (ACTIVATEII)

PAD - Peripheral Arterial Disease

Australia
Alucent Biomedical

Completed

Natural Vascular Scaffold (NVS) Therapy

Peripheral Arterial Disease | Peripheral Vascular Diseases | Catheterization, Peripheral

United States
MonTa Biosciences ApS
Allucent

Recruiting

Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours

Advanced Solid Tumor

Belgium, Denmark, Spain
Arthritis Innovation Corporation
Allucent

Active, not recruiting

A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacement

Post Operative Pain

United States
Biomedical Advanced Research and Development Authority
Rho Federal Systems Division, Inc.; Allucent

Not yet recruiting

Sublingual Atropine Bioequivalence by Route of Administration (SABER) (SABER)

Atropine Bioequivalence

United States
Orlucent, Inc

Enrolling by invitation

INTER-PATHOLOGIST READER STUDY

Nevi, Dysplastic

United States
Orlucent, Inc

Completed

Assessing Tissue Remodeling in the Skin Using SFI (Skin Fluorescence Imaging)

Skin Lesion | Melanoma (Skin) | Mole

United States
Orlucent, Inc

Completed

Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging

Skin Lesions

Israel
AvenCell Europe GmbH
Allucent

Recruiting

Dose-escalating Trial With Allo-RevCAR01-T Cells in Combination With CD123 Target Module (R-TM123) for Participants With Selected Hematologic Malignancies Positive for CD123

Acute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia Refractory

Germany
Lument AB

Terminated

A Randomized, Controlled Trial to Evaluate CT Image Quality Lumentin® 44

Subjects Referred to CT-examination of the Abdomen

Sweden
Orlucent, Inc

Unknown

Skin Fluorescent Imaging (SFI) System in Patients With Nevi

Nevus | Dysplasia; Epithelial

United States
Laurent Pharmaceuticals Inc.

Recruiting

Study of LAU-7b for the Treatment of Long COVID in Adults (ESSOR)

Long COVID

Canada
Laurent Pharmaceuticals Inc.

Active, not recruiting

Study of LAU-7b for the Treatment of COVID-19 Disease in Adults (RESOLUTION)

COVID-19 Disease

United States, Canada
R-Pharm
Ascent

Completed

A Pharmacokinetic Study of Narlaprevir as a Single Dose or With Ritonavir Combination in Patients With Hepatic Impairment and Healthy Matched Volunteers

Hepatic Impairment

Georgia, Russian Federation
Nova Biomedical

Suspended

Performance Study of Nova StatStrip® Blood Glucose Monitoring Test System on Neonatal Capillary Blood

Healthy and Unhealthy Neonates

China
Synapse Biomedical

Active, not recruiting

Randomized Study of TransAeris® System in Cardiac Surgery Patients at Risk of Prolonged Mechanical Ventilation (ERAS)

Ventilator Induced Diaphragm Dysfunction

United States
TVAX Biomedical

Completed

Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma

Glioma | Glioblastoma Multiforme | High Grade Astrocytoma

United States
FAST BioMedical

Completed

Pilot Study to Evaluate Safety, Tolerability, and Performance of the FAST PV Technology™ in Chronic Dialysis Patients

End Stage Renal Disease

United States
Nova Biomedical

Completed

Evaluation of the Analytical Performance of ALLEGRO™ Instrument

Kidney Diseases | Diabetes Mellitus | Metabolic Disease

United States
Gecko Biomedical

Completed

First In-human Use of SETALUM™ Sealant: The BlueSeal Clinical Study

Vascular Diseases
Crux Biomedical

Completed

Crux Biomedical Evaluation of the Crux Inferior Vena Cava Filter 4 (RETRIEVE 4)

Pulmonary Embolism

New Zealand, Australia
Agen Biomedical

Completed

Clinical Trial to Evaluate the Accuracy of [99mTc] ThromboView in the Detection of Deep Vein Thrombosis

Deep Vein Thrombosis

United States, Canada
Lumen Biomedical

Completed

Xtract™ Aspiration Catheter Registry Study

Fresh Soft Emboli or Thrombi in the Arteries.

New Zealand
Lumen Biomedical

Completed

EPIC US Feasibility Study: Use of the FiberNet® Emboli Protection Device in Carotid Artery Stenting

Carotid Artery Stenosis

United States
Point Biomedical

Completed

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease 007

Coronary Artery Disease

United States
Point Biomedical

Terminated

Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent

Coronary Artery Disease

United States
Point Biomedical

Terminated

Evaluation and Optimization of PB127 Myocardial Perfusion Echocardiography on Ultrasound Systems

Coronary Artery Disease | Healthy

United States
TVAX Biomedical

Available

TVI-Brain-1 in Expanded Access Patient

Recurrent Glioblastoma

United States
TVAX Biomedical

Completed

Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma

Glioblastoma Multiforme | Grade IV Astrocytoma | Grade IV Glioma

United States
NXT Biomedical

Enrolling by invitation

Rivet PVS Therapy in Group 2 PH-HFpEF

Heart Failure | Pulmonary Hypertension

United States
Synapse Biomedical

Completed

Pilot Study of TransAeris® System in Surgical Patients at Risk of Prolonged Mechanical Ventilation (TRANSITION)

Ventilator-Induced Diaphragm Dysfunction

United States
Ascendance Biomedical

Completed

Inovium Ovarian Rejuvenation Trials

Infertility | Menopause | Menopause, Premature | Infertility, Female | Premature Ovarian Failure | Menopause Related Conditions | Perimenopausal Disorder | Infertility Unexplained | Menopause Premature Symptomatic | Menopause Premature Asymptomatic | Premature Ovarian Failure, Familial | Premature Ovarian Failure... and other conditions

United States
Crux Biomedical

Completed

Crux Biomedical Vena Cava Filter Study - United States (RETRIEVE 2)

Pulmonary Embolism

United States
United Biomedical

Completed

Study to Evaluate Safety and Pharmacokinetics of UB-421 Antibody in HIV-1 Infected Adults

HIV-1 Infection in Adults (Asymptomatic)

Taiwan
Lumen Biomedical

Completed

The RETRIEVE Study: Use of the FiberNet® Embolic Protection System in Saphenous Vein Grafts (RETRIEVE)

Myocardial Ischemia | Embolism | Saphenous Vein Graft Disease

United States
Point Biomedical

Completed

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease

Coronary Artery Disease

United States
Point Biomedical

Completed

Familiarization and Safety Study of PB127 Ultrasound Contrast Agent

Coronary Artery Disease

United States
Point Biomedical

Terminated

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent for Diagnosis of Coronary Artery Disease (POINT II)

Coronary Artery Disease

United States
Point Biomedical

Completed

Dose Finding Study of PB127 Ultrasound Contrast Agent in Healthy Volunteers and Patients With Coronary Artery Disease

Coronary Artery Disease | Healthy

United States
Laurent Kaiser

Active, not recruiting

Blood Virome After Haploidentical Hematopoietic Stem Cell Transplantation, a Pilot Study

Haploidentical Hematopoietic Stem Cell Transplantation

Switzerland
Orlucent, Inc
Clalit Health Services

Completed

Pilot Study to Determine Feasibility of Benign and Malignant Skin Lesion Detection.

Skin Lesions
ABK Biomedical

Recruiting

Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma | Liver Cancer | Hepatocellular Carcinoma Non-resectable

United States
KerNel Biomedical

Recruiting

Evaluation of the Feasibility of Remote Monitoring of Mechanical In-exsufflation Devices in Paralytic and Neuromuscular Patients Treated at Home. (TELE-INEX)

Neuromuscular Diseases | Scoliosis

France
Maxwell Biomedical

Recruiting

Initial Experience With Spatial Resynchronization Therapy in Patients With Atrial Fibrillation (SR-TheAF)

Atrial Fibrillation

Georgia
NXT Biomedical

Not yet recruiting

Rivet PVS Therapy in Group 2 PH-HFpEF Canada

Heart Failure | Pulmonary Hypertension

Canada
ABK Biomedical

Completed

Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable HCC and mCRC

Metastatic Colorectal Cancer | Liver Cancer | Hepatocellular Carcinoma Non-resectable

New Zealand
Enopace Biomedical

Terminated

Endovascular NeuromoDulation Treatment fOr Heart Failure Patients (ENDO-HF)

Heart Failure

Croatia, Belgium, Israel, Greece

Clinical Trials Sponsored by Alucent Biomedical

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations